Compare MRVI & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | IPI |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.8M | 380.0M |
| IPO Year | 2020 | 2008 |
| Metric | MRVI | IPI |
|---|---|---|
| Price | $2.93 | $33.07 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 7 | 1 |
| Target Price | $4.57 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 1.1M | 205.3K |
| Earning Date | 02-25-2026 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $192,435,000.00 | ★ $222,728,000.00 |
| Revenue This Year | N/A | $23.98 |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $1.67 | $20.86 |
| 52 Week High | $4.40 | $39.01 |
| Indicator | MRVI | IPI |
|---|---|---|
| Relative Strength Index (RSI) | 30.37 | 51.95 |
| Support Level | $2.92 | $31.56 |
| Resistance Level | $3.17 | $35.78 |
| Average True Range (ATR) | 0.18 | 1.86 |
| MACD | -0.05 | -0.30 |
| Stochastic Oscillator | 4.52 | 35.62 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.